Results for tag: "Restenosis Drug"

The Restenosis Drug market is a subset of the Cardiovascular Drugs market, which focuses on drugs used to treat and prevent the narrowing of arteries due to the buildup of plaque. Restenosis drugs are used to reduce the risk of restenosis, a condition in which the artery walls become thickened and narrowed again after a procedure such as angioplasty or stenting. These drugs are typically administered through an injection or infusion, and may include anti-inflammatory agents, anticoagulants, and other medications. The Restenosis Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more